Article
Epigenome-wide DNA methylation analysis of late-stage mild cognitive impairment
16 Jan 2024
Abstract excerpt
Background: Patients with late-stage mild cognitive impairment (LMCI) have a higher risk of progression to Alzheimer’s disease (AD) than those with early-stage mild cognitive impairment (EMCI). However, previous studies have often pooled EMCI and LMCI patients into a single MCI group, with limited independent investigation into the pathogenesis of LMCI. Methods: In this study, we employed whole-genome methylation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
